Invivyd Stock Performance
| IVVD Stock | USD 0.76 0.05 6.17% |
Invivyd holds a performance score of 8 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -0.51, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Invivyd are expected to decrease at a much lower rate. During the bear market, Invivyd is likely to outperform the market. Use Invivyd potential upside, as well as the relationship between the kurtosis and day typical price , to analyze future returns on Invivyd.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Invivyd are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Invivyd exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Disposition of 65359 shares by Mcguire Terrance of Invivyd at 0.4668 subject to Rule 16b-3 | 12/16/2024 |
2 | Disposition of 97410 shares by Mcguire Terrance of Invivyd at 0.48 subject to Rule 16b-3 | 12/17/2024 |
3 | Disposition of 74764 shares by Mcguire Terrance of Invivyd at 0.4693 subject to Rule 16b-3 | 12/18/2024 |
4 | Disposition of 152067 shares by Mcguire Terrance of Invivyd at 0.4337 subject to Rule 16b-3 | 12/19/2024 |
5 | Disposition of 119805 shares by Mcguire Terrance of Invivyd at 0.4234 subject to Rule 16b-3 | 12/20/2024 |
6 | Disposition of 75776 shares by Mcguire Terrance of Invivyd at 0.4497 subject to Rule 16b-3 | 12/23/2024 |
7 | Disposition of 68161 shares by Mcguire Terrance of Invivyd at 0.5062 subject to Rule 16b-3 | 12/24/2024 |
8 | Disposition of 83817 shares by Mcguire Terrance of Invivyd at 0.5436 subject to Rule 16b-3 | 12/26/2024 |
9 | Disposition of 86545 shares by Mcguire Terrance of Invivyd at 0.4828 subject to Rule 16b-3 | 12/30/2024 |
10 | Disposition of 103474 shares by Mcguire Terrance of Invivyd at 0.4455 subject to Rule 16b-3 | 12/31/2024 |
11 | Invivyd Provides Another Positive SARS-CoV-2 Variant Data Analysis to Satisfy U.S. FDAs Gating Request for Completing Its Review of EUA Request for PEMGARDA for... | 01/27/2025 |
12 | Invivyd Inc Reports Q4 2024 Revenue of 13.8 Million, Slightly Below Estimates | 02/05/2025 |
13 | Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on ... | 02/10/2025 |
14 | Acquisition by Timothy Lee of 300000 shares of Invivyd subject to Rule 16b-3 | 02/14/2025 |
15 | 5 Stocks That More Than Doubled Halfway Through Q1 | 02/24/2025 |
16 | Acquisition by Andersen Jill of 500000 shares of Invivyd subject to Rule 16b-3 | 02/25/2025 |
17 | Invivyd Announces Continued Neutralizing Activity of PEMGARDA | 03/05/2025 |
18 | Insider Trading | 03/10/2025 |
19 | Disposition of tradable shares by Cotter Sara of Invivyd subject to Rule 16b-3 | 03/13/2025 |
| Begin Period Cash Flow | 92.1 M |
Invivyd |
Invivyd Relative Risk vs. Return Landscape
If you would invest 44.00 in Invivyd on December 18, 2024 and sell it today you would earn a total of 32.00 from holding Invivyd or generate 72.73% return on investment over 90 days. Invivyd is currently generating 3.2578% in daily expected returns and assumes 29.0569% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Invivyd, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Invivyd Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Invivyd's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Invivyd, and traders can use it to determine the average amount a Invivyd's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1121
| Best Portfolio | Best Equity | |||
| Good Returns | IVVD | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 29.06 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.26 actual daily | 65 65% of assets have lower returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Invivyd is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Invivyd by adding it to a well-diversified portfolio.
Invivyd Fundamentals Growth
Invivyd Stock prices reflect investors' perceptions of the future prospects and financial health of Invivyd, and Invivyd fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Invivyd Stock performance.
| Return On Equity | -1.37 | ||||
| Return On Asset | -0.67 | ||||
| Operating Margin | (6.70) % | ||||
| Current Valuation | (8.98 M) | ||||
| Shares Outstanding | 119.62 M | ||||
| Price To Book | 1.16 X | ||||
| Price To Sales | 8.32 X | ||||
| Gross Profit | 10.67 M | ||||
| EBITDA | (196.62 M) | ||||
| Net Income | (198.64 M) | ||||
| Cash And Equivalents | 418.67 M | ||||
| Cash Per Share | 3.84 X | ||||
| Total Debt | 2.17 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 9.14 X | ||||
| Book Value Per Share | 0.69 X | ||||
| Cash Flow From Operations | (173.16 M) | ||||
| Earnings Per Share | (1.95) X | ||||
| Market Capitalization | 96.25 M | ||||
| Total Asset | 229.18 M | ||||
| Retained Earnings | (732.07 M) | ||||
| Working Capital | 174.59 M | ||||
About Invivyd Performance
By analyzing Invivyd's fundamental ratios, stakeholders can gain valuable insights into Invivyd's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Invivyd has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Invivyd has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (255.12) | (267.88) | |
| Return On Tangible Assets | (1.00) | (1.05) | |
| Return On Capital Employed | (1.34) | (1.40) | |
| Return On Assets | (1.00) | (1.05) | |
| Return On Equity | (1.29) | (1.22) |
Things to note about Invivyd performance evaluation
Checking the ongoing alerts about Invivyd for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Invivyd help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Invivyd is way too risky over 90 days horizon | |
| Invivyd has some characteristics of a very speculative penny stock | |
| Invivyd appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (198.64 M) with profit before overhead, payroll, taxes, and interest of 10.67 M. | |
| Invivyd currently holds about 418.67 M in cash with (173.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Invivyd has a frail financial position based on the latest SEC disclosures | |
| Roughly 72.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of tradable shares by Cotter Sara of Invivyd subject to Rule 16b-3 |
- Analyzing Invivyd's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Invivyd's stock is overvalued or undervalued compared to its peers.
- Examining Invivyd's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Invivyd's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Invivyd's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Invivyd's stock. These opinions can provide insight into Invivyd's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Invivyd Stock analysis
When running Invivyd's price analysis, check to measure Invivyd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invivyd is operating at the current time. Most of Invivyd's value examination focuses on studying past and present price action to predict the probability of Invivyd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invivyd's price. Additionally, you may evaluate how the addition of Invivyd to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |